The Indonesian stock market has entered a severe downturn, with the Indeks Harga Saham Gabungan (IHSG) plunging 38% from its peak—a decline described as more severe than the market volatility experienced during the Covid-19 pandemic.
- Market Level: The IHSG fell to 5,594, marking a 5.5-year low.
- Weekly Performance: The index dropped 8.69% over the course of a single week.
- Market Valuation: Total market capitalization has reached Rp 9,807 T.
- Primary Drivers: Heavy selling pressure, currency weakness in the rupiah, and negative economic perceptions.
Drivers of the Market Decline
Market analysts point to a combination of macroeconomic factors and investor psychology as the catalysts for the current slump. According to local reports, the combination of intense selling pressure and the weakening of the rupiah has dragged the index to its lowest level in five and a half years.
Purbaya, an analyst cited in local media, identified the root cause of the continuous slide as a pervasive negative perception regarding the state of the economy. This sentiment has fueled a cycle of divestment, further depressing the index.
Comparing the Crash to the Pandemic
The scale of the current correction is particularly stark when measured against historical benchmarks. While the Covid-19 pandemic caused global market chaos, the current 38% drop from the peak exceeds the severity of that period’s decline for the IHSG.
The rapid erosion of value is evident in the weekly data, where the index shed 8.69% to close at 5,594, leaving the total market capitalization at Rp 9,807 T.
Investor Outlook and Stock Recommendations
Despite the volatility, some analysts are identifying specific opportunities for investors, though the general consensus remains cautious. Predictions suggest that the IHSG will likely remain under pressure in the near term.
Amidst this bearish environment, certain stocks have been highlighted as recommendations for those looking to navigate the current market conditions, including:
- BBNI (Bank Negara Indonesia)
- KLBF (Kalbe Farma)
- SIDO (Sido Muncul)
- TPIA (Chandra Asri Pacific)
